Clinical trial · Observational
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a multicenter, two-way, non-intervention study. the main purpose: Understand the current status of diagnosis and treatment of cholangiocarcinoma patients in China and observe the effect of different treatment options on patient recurrence and long-term survival Secondary purpose: 1. Exploring the actual clinical treatment situation and its compliance with the existing diagnosis and treatment of bile duct cancer 2. Exploring the establishment of clinical research standard fields and standards for diagnosis and treatment of bile duct cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cholangiocarcinoma | Cholangiocarcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- RFSR
- timeFrame
- 3 years
- description
- RFSR-Recurrence Free Survival Rate
Secondary outcomes (2)
- measure
- OS
- timeFrame
- 3 years
- description
- OS-Overall Survival
- measure
- RFS
- timeFrame
- 3 years
- description
- RFS-Recurrence Free Survival
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. above the age of 18 years old, male or female 2. clinical diagnosis of patients with cholangiocarcinoma 3. Child-Pugh classification of A, B 4. Eastern Cooperative Oncology Group scoring system (ECOG) score of 0-2 points Exclusion Criteria: * None
References
Publications (0)
Data not yet available